Trials / Sponsors / ReveraGen BioPharma, Inc.
ReveraGen BioPharma, Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) Becker Muscular Dystrophy | Phase 2 | 2022-07-07 |
| Withdrawn | Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis Pediatric Ulcerative Colitis | Phase 1 / Phase 2 | 2020-09-01 |
| Completed | A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2018-06-29 |
| Completed | Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2017-02-02 |
| Completed | An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2016-07-28 |
| Completed | A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2016-06-01 |
| Completed | A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Ph Healthy | Phase 1 | 2015-01-01 |